ARLENE GARCIA-CHAU: Open Payments
NPI 1710532650 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $302 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $292 |
| Madrigal Pharmaceuticals | 3 | $110 |
| Enterra Medical, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Celltrion USA Inc. | 1 | $21 |
Products named: SKYRIZI, REZDIFFRA, RINVOQ, EOHILIA, INJECTAFER, VEGZELMA, CREON.
Industry payments across TX — which companies pay providers there.
